'''Daledalin''' ('''UK-3557-15''') is an [[antidepressant]] which was [[chemical synthesis|synthesized]] and [[clinical trial|trialed]] for [[clinical depression|depression]] in the early 1970s, but was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA565&dq=daledalin&pg=PA565#v=onepage&q=daledalin&f=false}}</ref><ref name="doi10.1021/jm00277a017">{{cite journal | author = Canas-Rodriquez A, Leeming PR | title = N-Phenyl-2-indolinones and N-phenylindolines - New class of antidepressant agents | journal = Journal of Medicinal Chemistry | volume = 15 | issue = 7 | pages = 762–770 | year = 1972 | pmid = | doi = 10.1021/jm00277a017 | url = http://pubs.acs.org/doi/abs/10.1021/jm00277a017}}</ref><ref name="pmid4614944">{{cite journal | author = Edwards JG, Ollerenshaw DP | title = Daledalin tosylate: a controlled trial in depressive illness | journal = Current Medical Research and Opinion | volume = 2 | issue = 6 | pages = 305–12 | year = 1974 | pmid = 4614944 | doi = 10.1185/03007997409114763 | url = http://informahealthcare.com/doi/abs/10.1185/03007997409114763%20}}</ref> It is a [[binding selectivity|selective]] [[norepinephrine reuptake inhibitor]], with no significant effects on the [[reuptake]] of [[serotonin]] and [[dopamine]], and no [[antihistamine]] or [[anticholinergic]] properties.<ref name="doi10.1021/jm00277a017">{{cite journal | author = Canas-Rodriquez A, Leeming PR | title = N-Phenyl-2-indolinones and N-phenylindolines - New class of antidepressant agents | journal = Journal of Medicinal Chemistry | volume = 15 | issue = 7 | pages = 762–770 | year = 1972 | pmid = | doi = 10.1021/jm00277a017 | url = http://pubs.acs.org/doi/abs/10.1021/jm00277a017}}</ref>
